Outcome | Months | 95% CI |
---|---|---|
Median time to progression | 11.9 | 10.8–13.1 |
Median progression-free survival | 11.8 | 10.7–13.0 |
Median overall survival | 24.8 | 19.9–29.7 |
Response to treatment | N | % |
Complete response | 4 | 5.2 |
Partial response | 35 | 45.5 |
Stable disease | 26 | 33.8 |
Progressive disease | 5 | 6.5 |
Not evaluable | 7 | 9.1 |
Response rates | % | 95% CI |
Overall response rate | 50.6 | 39.1–62.0 |
Disease control rate | 84.4 | 74.0–91.3 |